CDK2/4/6-IN-1
Modify Date: 2025-08-25 16:36:51
CDK2/4/6-IN-1 structure
|
Common Name | CDK2/4/6-IN-1 | ||
|---|---|---|---|---|
| CAS Number | 2803837-13-8 | Molecular Weight | 438.50 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H22N4O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CDK2/4/6-IN-1CDK2/4/6-IN-1(example 29) is a CDK2/4/6 inhibitor with IC50 values of 2.5, 23.7 and 44.3 nM for CDK2, CDK4 and CDK6, respectively. CDK2/4/6-IN-1 can be used in cancer research[1]. |
| Name | CDK2/4/6-IN-1 |
|---|
| Description | CDK2/4/6-IN-1(example 29) is a CDK2/4/6 inhibitor with IC50 values of 2.5, 23.7 and 44.3 nM for CDK2, CDK4 and CDK6, respectively. CDK2/4/6-IN-1 can be used in cancer research[1]. |
|---|---|
| Related Catalog | |
| Target |
CDK2:2.5 nM (IC50) CDK4:23.7 nM (IC50) CDK6:44.3 nM (IC50) |
| In Vitro | CDK2/4/6-IN-1(example 29) (0-600 nM, 24 h) inhibits the proliferation of OVCAR3 and MCF7 cells with the IC50 values of 14.6 and 117.8 nM, respectively[1]. CDK2/4/6-IN-1(example 29) (0-600 nM, 24 h) inhibits phosphorylation of Rb protein in OVCAR3 and MCF7 cells with the IC50 values of 18 and 581 nM, respectively[1]. |
| In Vivo | CDK2/4/6-IN-1(example 29) (25 mg/kg or 50 mg/kg, once a day, orally) has a significant inhibitory effect on tumor growth[1]. The pharmacokinetic parameters of example 29 in BALB/c mice (10 mg/kg, p.o.) Parameters Cmax(ng/mL) Tmax(hr) AUClast(hr*ng/mL) T1/2(hr) PO 4050 0.5 10050 4.8The pharmacokinetic parameters of example 29 in BALB/c mice (3 mg/kg, i.v.) Parameters C0(ng/mL) T1/2(hr) AUClast(hr*ng/mL) Vss(L/Kg) IV 4407 0.7 3245 0.9 |
| References |
| Molecular Formula | C22H22N4O4S |
|---|---|
| Molecular Weight | 438.50 |
| InChIKey | XTZONGZKZYDCAY-XMSQKQJNSA-N |
| SMILES | C#Cc1cc2cnc(Nc3ccc(S(C)(=O)=O)cc3)nc2n(C2CCCC2(C)O)c1=O |